0001209191-18-021307.txt : 20180322
0001209191-18-021307.hdr.sgml : 20180322
20180322175115
ACCESSION NUMBER: 0001209191-18-021307
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180321
FILED AS OF DATE: 20180322
DATE AS OF CHANGE: 20180322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patni Rajiv
CENTRAL INDEX KEY: 0001616200
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36399
FILM NUMBER: 18707812
MAIL ADDRESS:
STREET 1: C/O OCERA THERAPEUTICS, INC.
STREET 2: 525 UNIVERSITY AVENUE, SUITE 610
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001328143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 421560076
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 750
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-450-3554
MAIL ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 750
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc
DATE OF NAME CHANGE: 20050524
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-21
0
0001328143
Adamas Pharmaceuticals Inc
ADMS
0001616200
Patni Rajiv
C/O ADAMAS PHARMACEUTICALS, INC.
1900 POWELL ST, STE 750
EMERYVILLE
CA
94608
0
1
0
0
Chief Medical Officer
Common Stock
2018-03-21
4
S
0
1252
25.94
D
21515
D
Pursuant to the mandatory sale to cover withholding tax requirements of the issuer's equity incentive plan, the shares were sold to cover the tax obligation realized upon the vesting of restricted stock units.
The shares were sold at prices ranging from $25.78 to $25.94. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/Jennifer Rhodes, as Attorney-in-Fact
2017-03-22